Tag: Enrollment

Posted on

MediciNova completes enrollment in Phase II asthma trial – Pharmaceutical Business Review

MediciNova completes enrollment in Phase II asthma trial
Pharmaceutical Business Review
MediciNova has completed enrollment in its Phase II trial (MN-221-CL-007) evaluating the safety and efficacy of MN-221 for treatment of acute exacerbations of asthma. The randomized, double-blind trial enrolled a total of 176 asthma patients in the …
MediciNova Completes Enrollment in Phase 2 MN-221 Trial Treating Patients …MarketWatch (press release)

all 8 news articles »

View full post on asthma – Google News

Posted on

MediciNova Completes Enrollment in Phase 2 MN-221 Trial Treating Patients … – MarketWatch (press release)

MediciNova Completes Enrollment in Phase 2 MN-221 Trial Treating Patients …
MarketWatch (press release)
Patients suffering from acute exacerbations of asthma in the emergency room who were not promptly responding to standard pharmacotherapy were enrolled in the study. MediciNova is currently in the process of auditing and organizing the data and …

and more »

View full post on asthma – Google News